<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN
        </div>
        <div class="card-body">
                <p>In all, 85% of Ewing&#39;s sarcoma family tumors (ESFT), a neoplasm of unknown histogenesis, express EWS-FLI1 transcription factor gene fusions. To characterize direct target genes avoiding artificial model systems, we cloned genomic DNA from ESFT chromatin precipitating with EWS-FLI1. We now present a comprehensive list of 99 putative transcription factor targets identified, for the first time, by a hypothesis-free approach based on physical interaction. Gene-derived chromatin fragments co-precipitating with EWS-FLI1 were nonrandomly distributed over the human genome and localized predominantly to the upstream region and the first two introns of the genes. At least 20% of putative direct EWS-FLI1 targets were neural genes. One-third of genes recovered showed a significant ESFT-specific expression pattern and were found to be altered upon RNAi-mediated knockdown of EWS-FLI1. Among them, MK-STYX, encoding a MAP kinase phosphatase-like protein, was consistently expressed in ESFT. EWS-FLI1 was found to drive MK-STYX expression by binding to a single ETS binding motif within the first gene intron. MK-STYX serves as precedence for successful recovery of direct EWS-FLI1 targets from the authentic ESFT cellular context, the most relevant system to study oncogenic mechanisms for the discovery of new therapeutic targets in this disease.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M16533">M16533</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:23122">ncbigene:23122</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6747">ncbigene:6747</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5218">ncbigene:5218</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3420">ncbigene:3420</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:25913">ncbigene:25913</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6518">ncbigene:6518</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10528">ncbigene:10528</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:987">ncbigene:987</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5095">ncbigene:5095</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:440">ncbigene:440</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1740">ncbigene:1740</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6907">ncbigene:6907</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2961">ncbigene:2961</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8555">ncbigene:8555</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51657">ncbigene:51657</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:40">ncbigene:40</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5981">ncbigene:5981</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:26047">ncbigene:26047</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M16533&#39;, name=&#39;SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN&#39;), definition=&#34;In all, 85% of Ewing&#39;s sarcoma family tumors (ESFT), a neoplasm of unknown histogenesis, express EWS-FLI1 transcription factor gene fusions. To characterize direct target genes avoiding artificial model systems, we cloned genomic DNA from ESFT chromatin precipitating with EWS-FLI1. We now present a comprehensive list of 99 putative transcription factor targets identified, for the first time, by a hypothesis-free approach based on physical interaction. Gene-derived chromatin fragments co-precipitating with EWS-FLI1 were nonrandomly distributed over the human genome and localized predominantly to the upstream region and the first two introns of the genes. At least 20% of putative direct EWS-FLI1 targets were neural genes. One-third of genes recovered showed a significant ESFT-specific expression pattern and were found to be altered upon RNAi-mediated knockdown of EWS-FLI1. Among them, MK-STYX, encoding a MAP kinase phosphatase-like protein, was consistently expressed in ESFT. EWS-FLI1 was found to drive MK-STYX expression by binding to a single ETS binding motif within the first gene intron. MK-STYX serves as precedence for successful recovery of direct EWS-FLI1 targets from the authentic ESFT cellular context, the most relevant system to study oncogenic mechanisms for the discovery of new therapeutic targets in this disease.&#34;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;15735734&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23122&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6747&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5218&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3420&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;25913&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6518&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10528&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;987&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5095&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;440&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1740&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6907&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2961&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8555&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51657&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;40&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5981&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;26047&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 1A&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>